Latest filing published 13 Jul 2018 for CASI Pharmaceuticals, Inc., €60k.
Insider track record
Sara B. Capitelli: trading record in brief
Sara B. Capitelli appears in our data through filings on CASI Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 12 April 2018 and the latest from 12 July 2018.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 13 July 2018, reports an option exercise of €60k in CASI Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sara B. Capitelli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares@ US$1.9913.3% of flowCommon StockSEC:0001144204-18-038360:0
- 8,400 shares@ US$7.4912.0% of flowCommon StockSEC:0001144204-18-038360:1
- 26,600 shares@ US$7.4938.1% of flowCommon StockSEC:0001144204-18-038360:2
- 26,978 shares@ US$0.884.3% of flowCommon StockSEC:0001144204-18-020555:0
- 8,200 shares@ US$6.629.8% of flowCommon StockSEC:0001144204-18-020555:1
- 18,778 shares@ US$6.6222.5% of flowCommon StockSEC:0001144204-18-020555:2
6 of 6 declarations